Dragonfly Energy Holdings Corp. — Filing Summary
Important entity context: This is Chardan NexTech Acquisition 2 Corp.’s Form 10-Q for the quarter ended March 31, 2022, not an operating-company 10-Q filed by Dragonfly Energy Holdings Corp. Chardan was a blank-check company searching for a business combination. After quarter-end, on May 15, 2022, Chardan and Dragonfly Energy Corp. entered into a merger agreement.
Business context and reporting period
The unaudited report covers the three months ended March 31, 2022, with balance-sheet comparisons to December 31, 2021 and operating results compared with the three months ended March 31, 2021. Chardan had not begun operations or generated operating revenue; its activities related to formation, its 2021 IPO, and pursuing a business combination.
Financial results and liquidity
- Revenue: No operating revenue. The company expected to generate operating revenue only after completing a business combination.
- Net income: $1.19 million, versus zero in Q1 2021; basic and diluted earnings per share were $0.08.
- Drivers: Results included a $1.43 million noncash gain from the decline in the fair value of private warrant liabilities and $16,066 of trust-account investment gains. These more than offset $208,206 of operating costs and $50,656 of franchise tax expense.
- Cash flow: $152,630 used in operating activities, compared with $77,118 used in Q1 2021. Cash declined from $799,808 at year-end to $647,178. No financing cash flow was reported in Q1 2022.
- Assets and liquidity: Total assets were $129.38 million, including $128.44 million held in the trust account. Working capital surplus was $729,325, down from $988,187 at December 31, 2021.
- Liabilities and equity: Total liabilities were $815,557, including $601,622 of private warrant liabilities. Stockholders’ equity was $167,484; 12.65 million redeemable shares were classified as temporary equity at $128.40 million.
- Debt and margins: No long-term debt or lease obligations were reported. Operating margins are not meaningful because there was no operating revenue.
Changes, outlook, and risks
- Compared with Q1 2021, reported net income increased from zero, primarily because of the warrant fair-value gain; Q1 2021 had no income or expenses in the statements of operations.
- Private warrant liabilities fell from $2.04 million at December 31, 2021 to $601,622 at March 31, 2022. The resulting fair-value gain was noncash and should not be viewed as operating earnings.
- Chardan had until August 13, 2022 to complete a business combination, with up to two three-month extensions to February 13, 2023, subject to required $1.265 million trust deposits per extension. Failure to complete a transaction would require liquidation and redemption of public shares; warrants would expire worthless.
- Management cited substantial doubt about Chardan’s ability to continue as a going concern if it did not complete a business combination within the permitted period. The filing contains an apparent date inconsistency: one passage says February 13, 2021, while the stated extension deadline elsewhere is February 13, 2023.
- The May 2022 merger agreement with Dragonfly is a subsequent event, not a completed transaction as of the quarter-end. Chardan disclosed COVID-19 and the Russia-Ukraine conflict as uncertainties whose effects were not then determinable.
- Disclosure controls were deemed ineffective because of a material weakness concerning accounting for complex financial instruments, following a prior revision related to redeemable common-stock classification. Management described remediation efforts but gave no assurance they would be effective.
- No legal proceedings or material changes to previously disclosed risk factors were reported. Chardan also disclosed a contingent business-combination marketing fee equal to 3.5% of IPO gross proceeds, payable only if a business combination closes.
Important facts for investors to verify
- Confirm which issuer’s financial statements are being analyzed: this filing reports Chardan SPAC results, not Dragonfly’s operating results.
- Review the merger agreement, transaction conditions, financing and redemption terms, and subsequent filings for the proposed Dragonfly combination.
- Assess the SPAC’s completion deadline, extension funding, redemption exposure, and available cash outside the trust account.
- Distinguish noncash warrant remeasurement gains from recurring operating performance and cash generation.
- Review remediation of the material weakness and resolve the going-concern deadline date inconsistency in the filing.